nodes	percent_of_prediction	percent_of_DWPC	metapath
Ramipril—BCHE—Irinotecan—pancreatic cancer	0.172	1	CbGbCtD
Ramipril—Mitiglinide—PPARG—pancreatic cancer	0.00315	0.663	CrCbGaD
Ramipril—Nateglinide—PPARG—pancreatic cancer	0.00161	0.337	CrCbGaD
Ramipril—Dysphagia—Doxorubicin—pancreatic cancer	0.000523	0.000635	CcSEcCtD
Ramipril—Leukopenia—Docetaxel—pancreatic cancer	0.000522	0.000634	CcSEcCtD
Ramipril—Body temperature increased—Fluorouracil—pancreatic cancer	0.000522	0.000633	CcSEcCtD
Ramipril—Eosinophilia—Doxorubicin—pancreatic cancer	0.000517	0.000628	CcSEcCtD
Ramipril—Palpitations—Docetaxel—pancreatic cancer	0.000516	0.000626	CcSEcCtD
Ramipril—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000516	0.000626	CcSEcCtD
Ramipril—Weight increased—Epirubicin—pancreatic cancer	0.000514	0.000624	CcSEcCtD
Ramipril—Loss of consciousness—Docetaxel—pancreatic cancer	0.000513	0.000623	CcSEcCtD
Ramipril—Pancreatitis—Doxorubicin—pancreatic cancer	0.000512	0.000622	CcSEcCtD
Ramipril—Cough—Docetaxel—pancreatic cancer	0.000509	0.000618	CcSEcCtD
Ramipril—Angina pectoris—Doxorubicin—pancreatic cancer	0.000509	0.000618	CcSEcCtD
Ramipril—Hypersensitivity—Irinotecan—pancreatic cancer	0.000507	0.000616	CcSEcCtD
Ramipril—Convulsion—Docetaxel—pancreatic cancer	0.000505	0.000614	CcSEcCtD
Ramipril—Bronchitis—Doxorubicin—pancreatic cancer	0.000503	0.00061	CcSEcCtD
Ramipril—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000499	0.000606	CcSEcCtD
Ramipril—Arthralgia—Docetaxel—pancreatic cancer	0.000497	0.000603	CcSEcCtD
Ramipril—Myalgia—Docetaxel—pancreatic cancer	0.000497	0.000603	CcSEcCtD
Ramipril—Chest pain—Docetaxel—pancreatic cancer	0.000497	0.000603	CcSEcCtD
Ramipril—Nausea—Sunitinib—pancreatic cancer	0.000497	0.000603	CcSEcCtD
Ramipril—Pancytopenia—Doxorubicin—pancreatic cancer	0.000496	0.000603	CcSEcCtD
Ramipril—Renal failure—Epirubicin—pancreatic cancer	0.000495	0.000601	CcSEcCtD
Ramipril—Asthenia—Irinotecan—pancreatic cancer	0.000494	0.0006	CcSEcCtD
Ramipril—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000494	0.0006	CcSEcCtD
Ramipril—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000493	0.000599	CcSEcCtD
Ramipril—Stomatitis—Epirubicin—pancreatic cancer	0.000491	0.000596	CcSEcCtD
Ramipril—Jaundice—Epirubicin—pancreatic cancer	0.000491	0.000596	CcSEcCtD
Ramipril—Urinary tract infection—Epirubicin—pancreatic cancer	0.000489	0.000595	CcSEcCtD
Ramipril—Conjunctivitis—Epirubicin—pancreatic cancer	0.000489	0.000595	CcSEcCtD
Ramipril—Neutropenia—Doxorubicin—pancreatic cancer	0.000489	0.000594	CcSEcCtD
Ramipril—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000486	0.00059	CcSEcCtD
Ramipril—Dry mouth—Docetaxel—pancreatic cancer	0.000486	0.00059	CcSEcCtD
Ramipril—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000486	0.00059	CcSEcCtD
Ramipril—Sweating—Epirubicin—pancreatic cancer	0.000483	0.000586	CcSEcCtD
Ramipril—Asthenia—Gemcitabine—pancreatic cancer	0.000481	0.000585	CcSEcCtD
Ramipril—Confusional state—Docetaxel—pancreatic cancer	0.00048	0.000583	CcSEcCtD
Ramipril—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000477	0.000579	CcSEcCtD
Ramipril—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000476	0.000578	CcSEcCtD
Ramipril—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000476	0.000578	CcSEcCtD
Ramipril—Oedema—Docetaxel—pancreatic cancer	0.000476	0.000578	CcSEcCtD
Ramipril—Weight increased—Doxorubicin—pancreatic cancer	0.000476	0.000578	CcSEcCtD
Ramipril—Epistaxis—Epirubicin—pancreatic cancer	0.000475	0.000577	CcSEcCtD
Ramipril—Pruritus—Gemcitabine—pancreatic cancer	0.000475	0.000577	CcSEcCtD
Ramipril—Sinusitis—Epirubicin—pancreatic cancer	0.000472	0.000574	CcSEcCtD
Ramipril—Diarrhoea—Irinotecan—pancreatic cancer	0.000471	0.000572	CcSEcCtD
Ramipril—Agranulocytosis—Epirubicin—pancreatic cancer	0.00047	0.000571	CcSEcCtD
Ramipril—Shock—Docetaxel—pancreatic cancer	0.000468	0.000569	CcSEcCtD
Ramipril—Nervous system disorder—Docetaxel—pancreatic cancer	0.000467	0.000567	CcSEcCtD
Ramipril—Pruritus—Fluorouracil—pancreatic cancer	0.000467	0.000567	CcSEcCtD
Ramipril—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000466	0.000566	CcSEcCtD
Ramipril—Tachycardia—Docetaxel—pancreatic cancer	0.000465	0.000564	CcSEcCtD
Ramipril—Skin disorder—Docetaxel—pancreatic cancer	0.000462	0.000562	CcSEcCtD
Ramipril—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000462	0.000561	CcSEcCtD
Ramipril—Diarrhoea—Gemcitabine—pancreatic cancer	0.000459	0.000558	CcSEcCtD
Ramipril—Renal failure—Doxorubicin—pancreatic cancer	0.000458	0.000556	CcSEcCtD
Ramipril—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000457	0.000555	CcSEcCtD
Ramipril—Dizziness—Irinotecan—pancreatic cancer	0.000455	0.000553	CcSEcCtD
Ramipril—Jaundice—Doxorubicin—pancreatic cancer	0.000454	0.000552	CcSEcCtD
Ramipril—Stomatitis—Doxorubicin—pancreatic cancer	0.000454	0.000552	CcSEcCtD
Ramipril—Anorexia—Docetaxel—pancreatic cancer	0.000454	0.000551	CcSEcCtD
Ramipril—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000453	0.00055	CcSEcCtD
Ramipril—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000453	0.00055	CcSEcCtD
Ramipril—Hepatitis—Epirubicin—pancreatic cancer	0.000452	0.000549	CcSEcCtD
Ramipril—Diarrhoea—Fluorouracil—pancreatic cancer	0.000451	0.000548	CcSEcCtD
Ramipril—Sweating—Doxorubicin—pancreatic cancer	0.000447	0.000543	CcSEcCtD
Ramipril—Oedema peripheral—Epirubicin—pancreatic cancer	0.000445	0.000541	CcSEcCtD
Ramipril—Hypotension—Docetaxel—pancreatic cancer	0.000445	0.00054	CcSEcCtD
Ramipril—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000444	0.00054	CcSEcCtD
Ramipril—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000441	0.000535	CcSEcCtD
Ramipril—Epistaxis—Doxorubicin—pancreatic cancer	0.000439	0.000534	CcSEcCtD
Ramipril—Vomiting—Irinotecan—pancreatic cancer	0.000438	0.000532	CcSEcCtD
Ramipril—Sinusitis—Doxorubicin—pancreatic cancer	0.000437	0.000531	CcSEcCtD
Ramipril—Dizziness—Fluorouracil—pancreatic cancer	0.000436	0.00053	CcSEcCtD
Ramipril—Visual impairment—Epirubicin—pancreatic cancer	0.000436	0.000529	CcSEcCtD
Ramipril—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000435	0.000528	CcSEcCtD
Ramipril—Rash—Irinotecan—pancreatic cancer	0.000434	0.000527	CcSEcCtD
Ramipril—Dermatitis—Irinotecan—pancreatic cancer	0.000434	0.000527	CcSEcCtD
Ramipril—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000434	0.000527	CcSEcCtD
Ramipril—Headache—Irinotecan—pancreatic cancer	0.000432	0.000524	CcSEcCtD
Ramipril—Insomnia—Docetaxel—pancreatic cancer	0.000431	0.000523	CcSEcCtD
Ramipril—Paraesthesia—Docetaxel—pancreatic cancer	0.000428	0.000519	CcSEcCtD
Ramipril—Erythema multiforme—Epirubicin—pancreatic cancer	0.000427	0.000519	CcSEcCtD
Ramipril—Vomiting—Gemcitabine—pancreatic cancer	0.000427	0.000518	CcSEcCtD
Ramipril—Dyspnoea—Docetaxel—pancreatic cancer	0.000425	0.000516	CcSEcCtD
Ramipril—Somnolence—Docetaxel—pancreatic cancer	0.000423	0.000514	CcSEcCtD
Ramipril—Rash—Gemcitabine—pancreatic cancer	0.000423	0.000514	CcSEcCtD
Ramipril—Dermatitis—Gemcitabine—pancreatic cancer	0.000423	0.000513	CcSEcCtD
Ramipril—Tinnitus—Epirubicin—pancreatic cancer	0.000421	0.000512	CcSEcCtD
Ramipril—Headache—Gemcitabine—pancreatic cancer	0.00042	0.000511	CcSEcCtD
Ramipril—Flushing—Epirubicin—pancreatic cancer	0.00042	0.00051	CcSEcCtD
Ramipril—Vomiting—Fluorouracil—pancreatic cancer	0.000419	0.000509	CcSEcCtD
Ramipril—Dyspepsia—Docetaxel—pancreatic cancer	0.000419	0.000509	CcSEcCtD
Ramipril—Hepatitis—Doxorubicin—pancreatic cancer	0.000418	0.000508	CcSEcCtD
Ramipril—Rash—Fluorouracil—pancreatic cancer	0.000416	0.000505	CcSEcCtD
Ramipril—Dermatitis—Fluorouracil—pancreatic cancer	0.000416	0.000505	CcSEcCtD
Ramipril—Decreased appetite—Docetaxel—pancreatic cancer	0.000414	0.000503	CcSEcCtD
Ramipril—Headache—Fluorouracil—pancreatic cancer	0.000413	0.000502	CcSEcCtD
Ramipril—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000412	0.0005	CcSEcCtD
Ramipril—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000411	0.000499	CcSEcCtD
Ramipril—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000411	0.000499	CcSEcCtD
Ramipril—Fatigue—Docetaxel—pancreatic cancer	0.000411	0.000499	CcSEcCtD
Ramipril—Nausea—Irinotecan—pancreatic cancer	0.000409	0.000497	CcSEcCtD
Ramipril—Immune system disorder—Epirubicin—pancreatic cancer	0.000408	0.000496	CcSEcCtD
Ramipril—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000407	0.000495	CcSEcCtD
Ramipril—Constipation—Docetaxel—pancreatic cancer	0.000407	0.000495	CcSEcCtD
Ramipril—Arrhythmia—Epirubicin—pancreatic cancer	0.000404	0.00049	CcSEcCtD
Ramipril—Visual impairment—Doxorubicin—pancreatic cancer	0.000403	0.00049	CcSEcCtD
Ramipril—Alopecia—Epirubicin—pancreatic cancer	0.000399	0.000485	CcSEcCtD
Ramipril—Nausea—Gemcitabine—pancreatic cancer	0.000399	0.000484	CcSEcCtD
Ramipril—Mental disorder—Epirubicin—pancreatic cancer	0.000396	0.000481	CcSEcCtD
Ramipril—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000395	0.00048	CcSEcCtD
Ramipril—Erythema—Epirubicin—pancreatic cancer	0.000394	0.000478	CcSEcCtD
Ramipril—Malnutrition—Epirubicin—pancreatic cancer	0.000394	0.000478	CcSEcCtD
Ramipril—Feeling abnormal—Docetaxel—pancreatic cancer	0.000392	0.000477	CcSEcCtD
Ramipril—Nausea—Fluorouracil—pancreatic cancer	0.000392	0.000476	CcSEcCtD
Ramipril—Tinnitus—Doxorubicin—pancreatic cancer	0.00039	0.000474	CcSEcCtD
Ramipril—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000389	0.000473	CcSEcCtD
Ramipril—Flushing—Doxorubicin—pancreatic cancer	0.000388	0.000471	CcSEcCtD
Ramipril—Tension—Epirubicin—pancreatic cancer	0.000386	0.000469	CcSEcCtD
Ramipril—Dysgeusia—Epirubicin—pancreatic cancer	0.000385	0.000468	CcSEcCtD
Ramipril—Nervousness—Epirubicin—pancreatic cancer	0.000382	0.000464	CcSEcCtD
Ramipril—Muscle spasms—Epirubicin—pancreatic cancer	0.000378	0.00046	CcSEcCtD
Ramipril—Immune system disorder—Doxorubicin—pancreatic cancer	0.000378	0.000459	CcSEcCtD
Ramipril—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000377	0.000458	CcSEcCtD
Ramipril—Abdominal pain—Docetaxel—pancreatic cancer	0.000376	0.000457	CcSEcCtD
Ramipril—Body temperature increased—Docetaxel—pancreatic cancer	0.000376	0.000457	CcSEcCtD
Ramipril—Arrhythmia—Doxorubicin—pancreatic cancer	0.000374	0.000454	CcSEcCtD
Ramipril—Alopecia—Doxorubicin—pancreatic cancer	0.00037	0.000449	CcSEcCtD
Ramipril—Mental disorder—Doxorubicin—pancreatic cancer	0.000366	0.000445	CcSEcCtD
Ramipril—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000365	0.000443	CcSEcCtD
Ramipril—Erythema—Doxorubicin—pancreatic cancer	0.000364	0.000442	CcSEcCtD
Ramipril—Malnutrition—Doxorubicin—pancreatic cancer	0.000364	0.000442	CcSEcCtD
Ramipril—Agitation—Epirubicin—pancreatic cancer	0.000362	0.000439	CcSEcCtD
Ramipril—Tension—Doxorubicin—pancreatic cancer	0.000357	0.000434	CcSEcCtD
Ramipril—Dysgeusia—Doxorubicin—pancreatic cancer	0.000357	0.000433	CcSEcCtD
Ramipril—Malaise—Epirubicin—pancreatic cancer	0.000355	0.000431	CcSEcCtD
Ramipril—Nervousness—Doxorubicin—pancreatic cancer	0.000354	0.00043	CcSEcCtD
Ramipril—Vertigo—Epirubicin—pancreatic cancer	0.000354	0.000429	CcSEcCtD
Ramipril—Syncope—Epirubicin—pancreatic cancer	0.000353	0.000429	CcSEcCtD
Ramipril—Leukopenia—Epirubicin—pancreatic cancer	0.000352	0.000428	CcSEcCtD
Ramipril—Hypersensitivity—Docetaxel—pancreatic cancer	0.000351	0.000426	CcSEcCtD
Ramipril—Muscle spasms—Doxorubicin—pancreatic cancer	0.00035	0.000425	CcSEcCtD
Ramipril—Palpitations—Epirubicin—pancreatic cancer	0.000348	0.000422	CcSEcCtD
Ramipril—Loss of consciousness—Epirubicin—pancreatic cancer	0.000346	0.00042	CcSEcCtD
Ramipril—Cough—Epirubicin—pancreatic cancer	0.000343	0.000417	CcSEcCtD
Ramipril—Asthenia—Docetaxel—pancreatic cancer	0.000342	0.000415	CcSEcCtD
Ramipril—Convulsion—Epirubicin—pancreatic cancer	0.000341	0.000414	CcSEcCtD
Ramipril—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000338	0.00041	CcSEcCtD
Ramipril—Pruritus—Docetaxel—pancreatic cancer	0.000337	0.000409	CcSEcCtD
Ramipril—Myalgia—Epirubicin—pancreatic cancer	0.000335	0.000407	CcSEcCtD
Ramipril—Chest pain—Epirubicin—pancreatic cancer	0.000335	0.000407	CcSEcCtD
Ramipril—Arthralgia—Epirubicin—pancreatic cancer	0.000335	0.000407	CcSEcCtD
Ramipril—Agitation—Doxorubicin—pancreatic cancer	0.000335	0.000406	CcSEcCtD
Ramipril—Anxiety—Epirubicin—pancreatic cancer	0.000334	0.000406	CcSEcCtD
Ramipril—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000333	0.000404	CcSEcCtD
Ramipril—Discomfort—Epirubicin—pancreatic cancer	0.000331	0.000402	CcSEcCtD
Ramipril—Malaise—Doxorubicin—pancreatic cancer	0.000328	0.000399	CcSEcCtD
Ramipril—Dry mouth—Epirubicin—pancreatic cancer	0.000328	0.000398	CcSEcCtD
Ramipril—Vertigo—Doxorubicin—pancreatic cancer	0.000327	0.000397	CcSEcCtD
Ramipril—Syncope—Doxorubicin—pancreatic cancer	0.000327	0.000397	CcSEcCtD
Ramipril—Leukopenia—Doxorubicin—pancreatic cancer	0.000326	0.000396	CcSEcCtD
Ramipril—Diarrhoea—Docetaxel—pancreatic cancer	0.000326	0.000396	CcSEcCtD
Ramipril—Confusional state—Epirubicin—pancreatic cancer	0.000324	0.000393	CcSEcCtD
Ramipril—Palpitations—Doxorubicin—pancreatic cancer	0.000322	0.000391	CcSEcCtD
Ramipril—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000321	0.00039	CcSEcCtD
Ramipril—Oedema—Epirubicin—pancreatic cancer	0.000321	0.00039	CcSEcCtD
Ramipril—Loss of consciousness—Doxorubicin—pancreatic cancer	0.00032	0.000389	CcSEcCtD
Ramipril—Cough—Doxorubicin—pancreatic cancer	0.000318	0.000386	CcSEcCtD
Ramipril—Shock—Epirubicin—pancreatic cancer	0.000316	0.000384	CcSEcCtD
Ramipril—Convulsion—Doxorubicin—pancreatic cancer	0.000315	0.000383	CcSEcCtD
Ramipril—Nervous system disorder—Epirubicin—pancreatic cancer	0.000315	0.000383	CcSEcCtD
Ramipril—Dizziness—Docetaxel—pancreatic cancer	0.000315	0.000382	CcSEcCtD
Ramipril—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000314	0.000382	CcSEcCtD
Ramipril—Tachycardia—Epirubicin—pancreatic cancer	0.000313	0.000381	CcSEcCtD
Ramipril—Skin disorder—Epirubicin—pancreatic cancer	0.000312	0.000379	CcSEcCtD
Ramipril—Hyperhidrosis—Epirubicin—pancreatic cancer	0.00031	0.000377	CcSEcCtD
Ramipril—Chest pain—Doxorubicin—pancreatic cancer	0.00031	0.000377	CcSEcCtD
Ramipril—Myalgia—Doxorubicin—pancreatic cancer	0.00031	0.000377	CcSEcCtD
Ramipril—Arthralgia—Doxorubicin—pancreatic cancer	0.00031	0.000377	CcSEcCtD
Ramipril—Anxiety—Doxorubicin—pancreatic cancer	0.000309	0.000375	CcSEcCtD
Ramipril—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000308	0.000374	CcSEcCtD
Ramipril—Discomfort—Doxorubicin—pancreatic cancer	0.000306	0.000372	CcSEcCtD
Ramipril—Anorexia—Epirubicin—pancreatic cancer	0.000306	0.000372	CcSEcCtD
Ramipril—Dry mouth—Doxorubicin—pancreatic cancer	0.000303	0.000368	CcSEcCtD
Ramipril—Vomiting—Docetaxel—pancreatic cancer	0.000303	0.000368	CcSEcCtD
Ramipril—Rash—Docetaxel—pancreatic cancer	0.0003	0.000365	CcSEcCtD
Ramipril—Hypotension—Epirubicin—pancreatic cancer	0.0003	0.000365	CcSEcCtD
Ramipril—Dermatitis—Docetaxel—pancreatic cancer	0.0003	0.000364	CcSEcCtD
Ramipril—Confusional state—Doxorubicin—pancreatic cancer	0.0003	0.000364	CcSEcCtD
Ramipril—Headache—Docetaxel—pancreatic cancer	0.000298	0.000362	CcSEcCtD
Ramipril—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000297	0.000361	CcSEcCtD
Ramipril—Oedema—Doxorubicin—pancreatic cancer	0.000297	0.000361	CcSEcCtD
Ramipril—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000293	0.000355	CcSEcCtD
Ramipril—Shock—Doxorubicin—pancreatic cancer	0.000292	0.000355	CcSEcCtD
Ramipril—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000291	0.000354	CcSEcCtD
Ramipril—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000291	0.000353	CcSEcCtD
Ramipril—Insomnia—Epirubicin—pancreatic cancer	0.00029	0.000353	CcSEcCtD
Ramipril—Tachycardia—Doxorubicin—pancreatic cancer	0.00029	0.000352	CcSEcCtD
Ramipril—Skin disorder—Doxorubicin—pancreatic cancer	0.000289	0.000351	CcSEcCtD
Ramipril—Paraesthesia—Epirubicin—pancreatic cancer	0.000288	0.00035	CcSEcCtD
Ramipril—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000287	0.000349	CcSEcCtD
Ramipril—Dyspnoea—Epirubicin—pancreatic cancer	0.000286	0.000348	CcSEcCtD
Ramipril—Somnolence—Epirubicin—pancreatic cancer	0.000286	0.000347	CcSEcCtD
Ramipril—Anorexia—Doxorubicin—pancreatic cancer	0.000283	0.000344	CcSEcCtD
Ramipril—Nausea—Docetaxel—pancreatic cancer	0.000283	0.000344	CcSEcCtD
Ramipril—Dyspepsia—Epirubicin—pancreatic cancer	0.000283	0.000343	CcSEcCtD
Ramipril—Decreased appetite—Epirubicin—pancreatic cancer	0.000279	0.000339	CcSEcCtD
Ramipril—Hypotension—Doxorubicin—pancreatic cancer	0.000278	0.000337	CcSEcCtD
Ramipril—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000277	0.000337	CcSEcCtD
Ramipril—Fatigue—Epirubicin—pancreatic cancer	0.000277	0.000336	CcSEcCtD
Ramipril—Constipation—Epirubicin—pancreatic cancer	0.000275	0.000334	CcSEcCtD
Ramipril—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000271	0.000329	CcSEcCtD
Ramipril—Insomnia—Doxorubicin—pancreatic cancer	0.000269	0.000326	CcSEcCtD
Ramipril—Paraesthesia—Doxorubicin—pancreatic cancer	0.000267	0.000324	CcSEcCtD
Ramipril—Dyspnoea—Doxorubicin—pancreatic cancer	0.000265	0.000322	CcSEcCtD
Ramipril—Feeling abnormal—Epirubicin—pancreatic cancer	0.000265	0.000321	CcSEcCtD
Ramipril—Somnolence—Doxorubicin—pancreatic cancer	0.000264	0.000321	CcSEcCtD
Ramipril—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000263	0.000319	CcSEcCtD
Ramipril—Dyspepsia—Doxorubicin—pancreatic cancer	0.000262	0.000318	CcSEcCtD
Ramipril—Decreased appetite—Doxorubicin—pancreatic cancer	0.000258	0.000314	CcSEcCtD
Ramipril—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000257	0.000312	CcSEcCtD
Ramipril—Fatigue—Doxorubicin—pancreatic cancer	0.000256	0.000311	CcSEcCtD
Ramipril—Urticaria—Epirubicin—pancreatic cancer	0.000255	0.00031	CcSEcCtD
Ramipril—Constipation—Doxorubicin—pancreatic cancer	0.000254	0.000309	CcSEcCtD
Ramipril—Abdominal pain—Epirubicin—pancreatic cancer	0.000254	0.000308	CcSEcCtD
Ramipril—Body temperature increased—Epirubicin—pancreatic cancer	0.000254	0.000308	CcSEcCtD
Ramipril—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000245	0.000297	CcSEcCtD
Ramipril—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000243	0.000295	CcSEcCtD
Ramipril—Hypersensitivity—Epirubicin—pancreatic cancer	0.000237	0.000287	CcSEcCtD
Ramipril—Urticaria—Doxorubicin—pancreatic cancer	0.000236	0.000287	CcSEcCtD
Ramipril—Abdominal pain—Doxorubicin—pancreatic cancer	0.000235	0.000285	CcSEcCtD
Ramipril—Body temperature increased—Doxorubicin—pancreatic cancer	0.000235	0.000285	CcSEcCtD
Ramipril—Asthenia—Epirubicin—pancreatic cancer	0.00023	0.00028	CcSEcCtD
Ramipril—Pruritus—Epirubicin—pancreatic cancer	0.000227	0.000276	CcSEcCtD
Ramipril—Diarrhoea—Epirubicin—pancreatic cancer	0.00022	0.000267	CcSEcCtD
Ramipril—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000219	0.000266	CcSEcCtD
Ramipril—Asthenia—Doxorubicin—pancreatic cancer	0.000213	0.000259	CcSEcCtD
Ramipril—Dizziness—Epirubicin—pancreatic cancer	0.000212	0.000258	CcSEcCtD
Ramipril—Pruritus—Doxorubicin—pancreatic cancer	0.00021	0.000255	CcSEcCtD
Ramipril—Vomiting—Epirubicin—pancreatic cancer	0.000204	0.000248	CcSEcCtD
Ramipril—Diarrhoea—Doxorubicin—pancreatic cancer	0.000203	0.000247	CcSEcCtD
Ramipril—Rash—Epirubicin—pancreatic cancer	0.000202	0.000246	CcSEcCtD
Ramipril—Dermatitis—Epirubicin—pancreatic cancer	0.000202	0.000246	CcSEcCtD
Ramipril—Headache—Epirubicin—pancreatic cancer	0.000201	0.000244	CcSEcCtD
Ramipril—Dizziness—Doxorubicin—pancreatic cancer	0.000197	0.000239	CcSEcCtD
Ramipril—Nausea—Epirubicin—pancreatic cancer	0.000191	0.000232	CcSEcCtD
Ramipril—Vomiting—Doxorubicin—pancreatic cancer	0.000189	0.000229	CcSEcCtD
Ramipril—Rash—Doxorubicin—pancreatic cancer	0.000187	0.000228	CcSEcCtD
Ramipril—Dermatitis—Doxorubicin—pancreatic cancer	0.000187	0.000227	CcSEcCtD
Ramipril—Headache—Doxorubicin—pancreatic cancer	0.000186	0.000226	CcSEcCtD
Ramipril—Nausea—Doxorubicin—pancreatic cancer	0.000177	0.000214	CcSEcCtD
